Advanced Cell Diagnostics

Provider of the most
sensitive and specific RNA
in situ hybridization technology
Banner Image


  Secondary Navigation


Interested in information on new applications, interesting publications, new probe lists, newsletters or case studies? Enter your email address below.

Critical breakthroughs for Personalized Medicine

Advanced Cell Diagnostics is developing a line of novel tissue-based cancer diagnostic tests based on our proprietary RNAscope® Technology. Our diagnostic pipeline represents a breakthrough for tissue-based diagnostic pathology utilizing in situ hybridization, and provides a unique combination of single-molecule RNA detection, antibody-free methodology, walk-away assay automation, and digital data analysis. Together, these capabilities ascribe RNAscope® in situ hybridization (RNA-ISH) based diagnostic tests with both the sensitivity of quantitative RT-PCR and the histopathological context of immunohistocheistry (IHC), which together are essential for understanding the molecular complexity and heterogeneity of cancer. By enabling pathologists with powerful tools for characterizing a patient’s tumor, we are committed to make personalized medicine a reality, with a positive impact on patient care.

Tracker Pixel for Entry